Modelling the Cost Effectiveness of Rituximab in Chronic Lymphocytic Leukaemia in First-Line Therapy and Following Relapse
PharmacoEconomics (Auckland)（2014）
关键词
Chronic Lymphocytic Leukaemia,Hazard Rate,Fludarabine,National Comprehensive Cancer Network,Chronic Lymphocytic Leukaemia Patient
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要